Effect of Recombinant Surfactant Protein C–Based Surfactant on the Acute Respiratory Distress Syndrome

New England Journal of Medicine - United States
doi 10.1056/nejmoa033181
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Massachusetts Medical Society

Related search

Surfactant Treatment for Acute Respiratory Distress Syndrome

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1999English

Surfactant Medication for Acute Respiratory Distress Syndrome

Thorax
PulmonaryRespiratory Medicine
1997English

Surfactant Protein-B Polymorphisms and Mortality in the Acute Respiratory Distress Syndrome*

Critical Care Medicine
Critical CareIntensive Care Medicine
2008English

Exogenous Surfactant Therapy for Pediatric Patients With Acute Respiratory Distress Syndrome

Canadian Respiratory Journal
MedicinePulmonaryRespiratory Medicine
1997English

Recombinant Surfactant Protein C–based Surfactant for Patients With Severe Direct Lung Injury

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2011English

Treatment of Acute Respiratory Distress Syndrome in Secondary Surfactant Deficiency in Neonates

Paediatrica Indonesiana
2007English

Surfactant Protein a (SP-A) Is a Prognostic Molecular Biomarker in Acute Respiratory Distress Syndrome

Obshchaya Reanimatologiya
Critical CareIntensive Care Medicine
2013English

Exogenous Natural Surfactant for Treatment of Acute Lung Injury and the Acute Respiratory Distress Syndrome

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2009English

Surfactant Therapy for Respiratory Distress Syndrome in Preterm Neonates

Jornal de Pediatria
Child HealthPediatricsPerinatology
1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy